Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

More black men will needlessly die unless a targeted prostate cancer screening programme is introduced as a priority, a campaigner has warned. Alfred Samuels said it 'should send alarm bells' that ...

Instead of detecting prostate cancer in the body, this test analyses men's DNA to identify those who were born with the highest risk of developing the disease, by looking for 130 specific genetic ...

A new spit test for prostate cancer which can be done at home may be better than current testing methods, a study suggests. Experts have developed a simple saliva test which analyses genetic ...

A Nigerian researcher, Dr Jerry Adeyemo, has identified alternative therapies that could help in the treatment of prostate cancer. Adeyemo said these alternative therapies, which are less ...

The prostate-specific antigen (PSA) test is a blood test which is currently used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not ...

The current prostate-specific antigen (PSA) test’s tendency to over-diagnose patients who would have lived happily without needing treatment has meant that officials have resisted calls for a ...